Dr. Michael Kovochich is a Managing Health Scientist with over 9 years of consulting experience at Cardno ChemRisk. His main areas of training and expertise are in molecular toxicology, immunology, and risk assessment. Dr. Kovochich also has significant experience with the design and analysis of in vitro and in vivo mammalian toxicology assays. He has managed and led numerous medical device projects including the assessment of outcomes and toxicological aspects of metal-on-metal hip implants. Over the past 15 years, Dr. Kovochich has published over 40 peer reviewed publications and conference abstracts on the topics of risk assessment, toxicology, immunology, particle characterization methods, and medical devices.

Dr. Kovochich completed his PhD at the University of California, Los Angeles in MicrobioIogy, Immunology, and Molecular Genetics with an emphasis in Molecular Toxicology. His research projects at UCLA involved air pollution toxicology, nanoparticle toxicology, as well as material science engineering and efficacy testing associated with various drug delivery systems. His research on nanoparticles led to various publications on topics such as the toxicology of ultrafine air pollution particles, cellular responses to fullerene nanoparticles, and drug delivery/toxicity of novel silica nanoparticles in cancer cells. Dr. Kovochich also finished his work at UCLA where he designed, engineered, and tested the first nanoparticle to be used in HIV latency therapy. During his doctoral work, Dr. Kovochich received multiple fellowships from the UC Toxic Substances Research and Teaching Program where he completed class work on molecular toxicology with an emphasis on principles of nanotoxicology.

As a consultant, Dr. Kovochich has led several efforts related to understanding potential exposure, toxicology and risk associated with various nanomaterials including nickel nanoparticles, carbon nanotubes, and metal-on-metal wear debris nanoparticles. He has also provided consulting expertise and managed projects related to medical device research, nanoparticle toxicology assessments, perfluoroalkyl substances, and asbestos risk assessment.


  • PhD, Microbiology, Immunology and Molecular Genetics University of California, Los Angeles, 2011
  • BS, Biological Sciences, Marquette University, Milwaukee, 2003

Professional Associations

  • Society of Toxicology (SOT): 2008 - Present

Most Recent Awards/Professional Honors

  • Early Toxicologist Award from the Mid-West Regional Chapter of the Society of Toxicology, 2019
  • Society of Toxicology Best Published Paper in Medical Device and Combination Product Specialty Section. March 2017. Baltimore, MD.
  • UCLA AIDS Institute, Center for AIDS Research Fellowship, University of California, Los Angeles, 2010
  • UC Toxic Substances Research and Teaching Program Fellowship, University of California, Los Angeles, 2008
  • UC Toxic Substances Research and Teaching Program Fellowship, University of California, Los Angeles, 2007